Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

µÎ°æºÎ¾Ç¼ºÁ¾¾ç¼¼Æ÷ÁÖÀÇ Ç×¾ÏÁ¦°¨¼ö¼º ½ÃÇè¿¡ °üÇÑ ½ÇÇèÀû ¿¬±¸

Chemosensitivity of cancer cells to antioancer drugs using dye exclusion assay, [3H] thymidine incorporation, and clonogenic assay

Áø¿ìÁ¤,
¼Ò¼Ó »ó¼¼Á¤º¸
Áø¿ìÁ¤ (  ) - ÀüºÏ´ëÇб³

Abstract


the in vitro predictive tests in cancer chamotherapy of cancer cell lines to anticancer drugs were determined using novel dye exclusion assay [NDEA], [3H] thymidine incorporation, and clonogenic assay [CA>. Antitumor effect of Bleomycin,
Cis-platin,
Vinblastine, Methotrexate to Hep-2, B16 cell lines using rapid assays was compared with [CA> in this study.
In dye exclusion assay of B 16 cell line, cancer cells were sensitive to Bleomycin at all concentrations, to Vinblastine at the level of peak plasma concentration [PPC], ¡¿1/10 [PPC](P<0.05). and bleomycin revealed relatively good cytotoxicity
than
that
of CDDP and vinblastine at ¡¿10 [PPC], (P<0.05).
Hep-2 cell swere resistive to methotrexate at the level of ¡¿100 [PPC] (P<0.05)
In [3H] thymidine incorporation assay, B 16 cells were sensitive to Bleomycin, CDDP, Vinblastine at the level of [PPC], ¡¿10 [PPC] (P<0.01).
Dose-dependent drugs of bleomycin, CDDP were more sensitive than Vinblastine at high concentration (P<0.05).
In clonogenic assay, Hep-2 cell line was sensitive to three drugs of all concentrations except ¡¿1/10 [PPC] of CDDP. B 16 cell line was sensitive to all drugs (P<0.01).
In comparison of chemosensitivity tests among three assays, the results were correlated (¥ã=0.99, P<0.05).

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed